Skip to content

ServiceTitan, Inc. TTAN Acquired in-process research and development

Acquired in-process research and development at other companies

ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$684.75K
Mid-America Apartment Communities logo
Mid-America Apartment CommunitiesMAA
$75.26M+13.6%
Cboe Global Markets logo
Cboe Global MarketsCBOE
$0-100%
Belden logo
BeldenBDC
$30.09M+5.9%
Biogen logo
BiogenBIIB
$35M
RBC Bearings logo
RBC BearingsRBC
$8.6M+4.2%

Other financials

Income statement

See full
Revenue$268.8M+24.6%
Gross profit$193.8M+30.6%
Operating income-$25.8M+48.0%
Net income-$22.8M+50.8%
EPS (diluted)-$0.24+52.9%

Balance sheet

See full
Cash & equivalents$421.5M+0.3%
Total debt$51.0M-68.4%
Total equity$1.6B+7.3%
Total assets$1.7B+1.2%

Cash flow

See full
Operating cash flow-$1.6M+89.3%
CapEx$596.0K-53.9%
Free cash flow-$2.2M+86.4%

Valuation

See full
Market cap$6.13B-50.1%
Enterprise value$5.76B-52.3%
P/S-9.0×

Profitability

See full
Gross margin70.9%+4.4pp
Operating margin-14.3%-4.7pp
Net margin-13.4%-4.6pp
FCF margin11.7%+7.2pp

Returns & leverage

See full
Return on equity-9%
Debt / equity-0.1×
Current ratio4.4×-0.4×

Where this comes from

Reported directly by ServiceTitan, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfIntangibleAssets.

The official record: ServiceTitan, Inc.’s 10-K, filed March 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ServiceTitan, Inc.'s acquired in-process research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ServiceTitan, Inc.'s acquired in-process research and development?
ServiceTitan, Inc. (TTAN) reported acquired in-process research and development of $684.75K in Q4 2023.
What does acquired in-process research and development mean?
This represents the cash paid for the acquisition of in-process research and development projects from other entities. It highlights the company's strategy of buying external innovation to accelerate product development cycles. Investors use this to evaluate the effectiveness of inorganic growth strategies in the R&D pipeline.